James N. Hollenhorst
Directeur/Membre du Conseil chez Gen9, Inc.
Profil
James N.
Hollenhorst is currently a Director at Gen9, Inc. He was previously a Senior Director-Technology at Agilent Technologies, Inc. Hollenhorst holds a graduate degree and a doctorate from Stanford University and an undergraduate degree from the University of Minnesota.
Postes actifs de James N. Hollenhorst
| Sociétés | Poste | Début |
|---|---|---|
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de James N. Hollenhorst
| Sociétés | Poste | Fin |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Formation de James N. Hollenhorst
| University of Minnesota | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AGILENT TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Health Technology |